BioSpace News Archive

Business

Cytek® Biosciences Names William McCombe Chief Financial Officer

Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that William (Bill) McCombe has been appointed chief financial officer of the company effective immediately.

March 19, 2024
·
7 min read
2024 Sanofi Biogenius Canada Grants open for applications

sanofi-aventis Canada inc. is pleased to announce that applications for the 2024 Sanofi Biogenius Canada Grants are now open.

March 19, 2024
·
4 min read
Business

Syra Health To Discuss Fourth Quarter and Fiscal Year 2023 Financial Results

Syra Health Corp. (NASDAQ: SYRA), (“Syra Health” or the “Company”) announced today that it will report financial results for its fourth quarter and fiscal year 2023 ended December 31, 2023, on Monday, March 25, 2024.

March 19, 2024
·
1 min read
Business

Aegis Life Receives Investment to Continue Development of DNA-Encoded Therapeutic Antibodies Against Infectious Diseases Using the Fusogenix PLV Platform

Aegis Life receives a program-related investment of $4.45M from the Bill & Melinda Gates Foundation.

March 19, 2024
·
6 min read
Business

ATCC Announces Award from the National Cancer Institute to Provide Biospecimen Processing Services and Assays for Cancer Research

ATCC will continue to support the National Cancer Institute’s (NCI) mission to prevent cancer and the Division of Cancer Epidemiology and Genetics (DCEG) Biospecimen Activity and Assay Support (BAAS) program.

March 19, 2024
·
3 min read
Mainstay Medical Announces Publication of the First Neuromodulation Study for Low Back Pain with 5-Year Follow-Up

Mainstay Medical Holdings plc announced the publication of the 5-year follow up from the ReActiv8-B randomized, sham-controlled, double-blinded trial.

March 19, 2024
·
4 min read
Business

Rapport Therapeutics Appoints Pioneering Industry Leader John Maraganore to Board of Directors

Rapport Therapeutics, Inc. today announced the appointment of John Maraganore, Ph.D., to its Board of Directors.

March 19, 2024
·
3 min read
BioMidwest

Meitheal Pharmaceuticals Announces Recent Business Progress Reinforcing Commitment to Sustainable Generics Development

Meitheal Pharmaceuticals, Inc. announced recent progress for its generic injectables portfolio, underscoring the Company’s commitment to serve as a sustainable partner for generics development in the U.S.

March 19, 2024
·
4 min read
Business

AffyImmune Therapeutics Appoints Matt Britz as Chief Executive Officer and Pete Gelinas as SVP of CMC

AffyImmune Therapeutics, Inc announced today the appointment of Matt Britz to Chief Executive Officer and Pete Gelinas as Senior Vice President of Chemistry, Manufacturing, and Controls.

March 19, 2024
·
4 min read
Business

Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System

Nascent Biotech, Inc. and HypoSpray Pharma announced today a collaboration to develop an alternative delivery mechanism for patients who can benefit from Pritumumab.

March 19, 2024
·
4 min read